Rifabutin is an antibiotic of the rifamycin class, which is particularly active against mycobacteria, including those that occur in AIDS patients. Because clinical use will include long-term therapy, an extensive battery of long-term toxicity studies was carried out by the oral route, including carcinogenicity studies. An interesting feature was the occurrence of multinucleated hepatocytes (MNHs) in the rat. In some instances, as many as 25 nuclei occurred in a single cell. Light microscopy revealed a large hepatocyte with normal eosinophilic staining. The multiple nuclei stained like those present in the surrounding normal cells. Electron microscopy showed no abnormalities of the nuclei and no cell membranes within the cytoplasm. The customary organelles were present. MNHs were dose-and sex-related, starting from 10 mg/kg/day and being more evident in males. They began to appear after 5 wk of treatment and persisted over long periods of recovery ( I 2 mo), without showing any tendency for cell proliferation. The life-span of MNHs was similar to that of normal hepatocytes. MNHs were present in the carcinogenicity study, but there was no increase in liver tumors.
Carlo Erba in independent contract laboratories. Materials, methods, and results are to be reported separately (4). The details of the studies are given in Table I . In these, the customary investigations were performed including the recording of body weight, clinical signs, ophthalmoscopy, food and water consumption, hematology, and clinical biochemistry. At termination, a full necropsy was carried out, the customary organs were weighed, and pumerous tissues were examined for histopathologYFor these studies, rifabutin of pharmaceutical grade and 96.48% purity was obtained from the Department , . .... of R&D/Galenics, Farmitalia (Milan) and, similarly, rifampin of 94.6% purity was supplied by SPA (Milan).
Because MNHs were seen to occur in the liver of rats with evidence of a dose-related effect, further studies were carried out in this species. These are listed in Table 11 . During these additional studies, the same records were kept and the samc specimens taken as in the routine studies, but histopathology was limited to the liver.
The morphological examination of the liver was standardized for the majority of studies. For light 369 microscopy, specimens were taken from the median and left lobes, fixed in 10% buffered formalin, sectioned at 5-6 pm, and stained with H&E. All sections were examined by the same pathologist (GS). Special stains were also employed in individual cases including Schmorl's, Sudan black, periodic acidSchiff, Perl's, Toluidine blue, and Bielschowsky. For all studies, the pathologist classified MNHs only as those hepatocytes showing more than 3 nuclei. The MNHs were graded for all animals as few, several, or numerous, on the basis of the frequency with which they occurred in the 2 sections of liver (1 from the median lobe and 1 from the left lobe) that were examined for each animal. Electron microscopy ofthe liver was camed out in the rat, mouse, and monkey studies. Rats were selected from the 13-wk gavage studies on Sprague-Dawley rats treated every other day, the 13-wk gavage/diet/rifampin study, and the 13-wk gavage study on Wistar rats. The liver samples were fixed either in modified Karnowsky fluid or in 2% glutaraldehyde, postfixed in osmium tetroxide, and embedded in epon araldite.
Ultrathin sections of approximately 800 6 -were stained with uranyl acetate and lead citrate and ex? amined by transmission electron microscopy. Livers from the 12-1110 gavage studies in both cynomol- gus monkeys and mice as well as those from the 13-wk study in baboons were examined.
RESULTS
The morphology of MNHs was similar in all the studies in which they were observed, irrespective of the duration of the study. By light microscopy, they appeared as large hepatocytes containing up to 25 nuclei per cell, but with a few cells showing up to 40 nuclei (Figs. I and 2 ). The size and shape depended on the number of nuclei and the manner in which they were grouped within the cells. The nuclei were often arranged in clusters or circles giving a rounded shape to the cell or, alternatively, they were seen to be arranged in chains giving rise to an elongated shape. The appearance of the individual nuclei of MNHs was similar to that of the nuclei in the surrounding unaltered hepatocytes. They usually occupied a central position within the cell. No mitotic figures were noted either in MNHs or in the surrounding hepatocytes. The cytoplasm showed the normal staining typical of adjacent hepatocytes.
MNHs were generally distributed throughout the liver parenchyma without showing any preferential location in the lobules. They appeared in the periportal zone as well as in the midzonal and centri- lobular zones. The number and the location in the hepatic cords varied. They were most often noted singly inside each hepatic cord and at some distance from other cords containing MNHs. However, in those cases in which they were particularly numerous, they occurred close to each other in the same cord or in adjacent cords. There was no preferential distribution of MNHs in the different lobes of the liver, taking into account that no differences were noted in the 2 sections from 2 different lobes examined for each animal. The frequency of these cells varied considerably among animals in the same groups, although generally the incidence of ,animals in which MNHs were judged to be numerous increased with dose.
Electron microscopy confirmed the normal features of the nuclei and showed that the enlarged cell body contained no cell membranes within the cytoplasm. The customary organelles were present ( Fig.  3 
)-
MNHs were found to be related to treatment with rifabutin in almost all the studies in the rat. The effect was specific to the liver. No abnormal multinucleated cells were seen in other organs or tissues in the rat or in other species. The percent incidence of animals in which MNHs were observed is given in Table 111 .
The sum of these studies indicates that MNHs first become apparent after 5 wk of treatment at 100 m&kg/day. The incidence and grading of the change were dose-related, and males were more sensitive to the change than were females. In both sexes, all animals showed MNHs at doses of 200 mg/kg/day after 13 wk of treatment, and in some studies males receiving 28 mg/kg/day showed this 100% involvement at 26 wk. Even though treatment continued at these high doses, the incidence ofaffected animals began to'decrease after 52 wk of treatment and was markedly reduced to 28% involvement in males and 4% involvement in females after 104 wk at 60 mg/ kg/day. The lowest dose to induce MNHs was 10 mg/kg/day after 26 wk of treatment. The MNH response to treatment was studied chiefly in rats of the Sprague-Dawley strain, but it also occurred in rats of the Wistar strain. There was no difference between the effects of dosing in the diet versus that by gavage, but the incidence of involvement was reduced by dosing on every other day. Rats of the at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from same Sprague-Dawley strain dosed in the diet at a different facility showed a reduced incidence when compared to a similar study performed at Farmitalia Carlo Erba. In short-term studies lasting 2 and 4 wk no MNHs were observed, although the highest doses administered were 500 and 50 mg/kg/day, respectively. In the recovery studies no obvious reduction in incidence was seen after 25 wk without treatment in males receiving 100 mg/kg/day for 13 wk, but in both males and females of the Wistar strain dosed for 13 wk a reduction of the effect was evident aft& 52 wk without treatment, although positive results were still present in females that had previously been dosed at 50 and 100 mg/kg/day. No evidence indicated that MNHs were associated with proliferative changes even over the longest periods of dosing.
Although rifampin is a member of the samegroup of antibiotics, it did not give rise to the development of MNHs (Table 111) .
Although MNHs are the principal findings of interest, other changes were found in both the liver and other tissues. Most prominent of these was a gradual increase in the deposition of a brownishyellow pigment in macrophages at many sites. Males were more affected than females. The extent of the pigmentation increased to a marked degree in the long-term studies, at which time in the liver pigment was seen in Kuppfer cells, hepatocytes, and the bile duct epithelium. Some large deposits of pigment gave rise to a secondary local inflammatory response in-occasional animals, and there were also changes in' tlie bile duqts and adjacent connective tissue. Concurrently, centrilobular hepatocytic hypertrophy occurred at the higher dose levels, and there were associated increases in aspartate aminotransferase, alanine aminotransferase, total cholesterol, and total bilirubin. Liver weights were increased in both absolute and relative terms. There was no relationship between these changes and the severity of MNHs. Indeed, in some cases MNHs were absent while all the remaining entities were prominent. In mice and monkeys, while no MNHs were found, the general pattern of liver changes was present, although to a lesser degree, particularly in the monkeys.
DISCUSSION
A search of the literature revealed that MNHs have been reported in a wide range of conditions in humans and animals. A selection of these are listed in Table IV . During the search, care has been taken. to differentiate between the multinucleated form of a hepatocyte and a hepatocyte showing polyploidy. In polyploid cells, only 1 nucleus may be present but of a size to accommodate the number of' muitiples of the normal complement of chromosomes.
Although Table IV is not intended to be exhaustive, it does indicate that MNHs occur in infectious conditions, in nutritional deficiencies, in diseases of abnormal storage, and in response to bacterial toxins and to toxic chemicals. In some instances, the term "giant cells" has been used to describe the occurrence of MNHs, but either in illustrations or in the text the derivation of the cells was made clear. Articles that describe giant cells when the cells in question are foreign body giant cells have not been included in the list. The articles to which reference is made in Table IV are considered to be those most helpful on the topic of MNHs but are not necessarily the most recent or most complete with respect to the condition they describe. A list of conditions applicable in the human is given by Elsner (lo), and neonatal hepatocellular giant cell transformation in humans is reviewed by Montgomery and Ruebner (26) .
In addition to those conditions in which MNHs form part of an abnormal response in the liver, they are also known to occur spontaneously in normal tissue. Hepatocytes containing 2 or 4 nuclei are common. About a quarter of the cells in the liver of humans are binucleate (21) . In the rat, the number of binucleate cells increases with age (1 5), and Burek ( 5 ) provided an illustration of a MNH strongly resembling those found in the present study but which occurred in a 2-yr-old untreated control rat. In our own studies, a low background incidence was noted in controls aged more than 1 yr. Gellatly (13) described multinucleate cells in mice with up to 20 nuclei that occurred in less than 20% of animals fed a stock diet but in 65% fed an SSP diet, and Tucker and Baker (35) described such cells as a spontaneous finding in old mice. It is noteworthy that in these instances of spontaneous multinucleate cells the nuclei within the cells are regular and resemble the nuclei in the adjacent hepatocytes. The cytoplasm is also normal, being adequate to contain the nuclei but not disproportionately enlarged. In the majority of articles cited in Table IV , an adequate description or photomicrograph illustrating the MNH was found. While there are obvious weaknesses to this approach, it is also surprising to find how many of the photomicrographs illustrate similar cells, either with several cells shown in 1 field or with cells showing similar morphology in articles dealing with widely diverse conditions published decades apart from institutes on different continents. On the basis of these descriptions, there would appear to be different forms of MNHs.
The first type, which occurs spontaneously, conlains b.. regular nuclei that are similar in size and shape to those in the surrounding normal hepatocytes and are contained in a cell of a size just adequate to incorporatz them. The secondtypealso contains regular nuclei, but they are contained within an enlarged cell body with voluminous cytoplasm. In the third type, the nuclei are often enlarged and irregular, and the cell body again enlarged. Of the conditions listed in Table 111 , the majority is associated with the development of MNHs of the second type. The third type is only described in cases of toxicity with colchicine, thiourea, and methotrexate and in the neoplastic conditions of carcinoma and adenoma of the liver in infants and in rats.
The morphological pattern seen in the experiments that are the subject of this article falls into the first category, being similar to the appearance of MNHs that occur spontaneously and to those reported by Jones and Butler (1 6) as a response to a single dose of dioxin.
Although there is an association between the occurrence of MNHs and the eventual development of liver cancer in many instances already quoted, it is clear that cancer is not the inevitable sequel of this phenomenon. Such cells occur spontaneously in some instances, and although they are seen as an effect of treatment with rifabutin even after only 5 wk of dosing, continuing treatment did not give rise to cancer. Also, William and Watanabe (39) reported a study on the kinetics of hepatocarcinogenesis in the rat in which there was a shift from binucleated to mononucleated hepatocytes following 13 wk of exposure to N-2-fluorenylacetamideY indicating a shift opposite to that of the present.
Jones and Butler (16) suggested that in response to dioxin MNHs are formed by coalescence of parenchymal cells, although they also indicated that an alternative mechanism would be "formation by nuclear division of a single cell with incomplete cytoplasmic separation." Campbell and Gilbert (6) referred to several agents including aflatoxin, carbon tetrachloride vapor, and colchicine, proposing the formation of MNHs as a nonspecific reaction to injury. They considered that the cells originate from a single regenerate cell, and Elsner (1 0) considered that the same mechanism applies in some neonatal conditions in humans. Wilson and Leduc (40), while discussing the spontaneous occurrence of MNHs, described cells that contain multiple mitotic spindles. They thought that this could indicate that such cells develop from 1 cell rather than by fusion, although they favored the concept of fusion as the most likely mechanism.
With rifabutin the number of MNHs formed is dose-dependent, but even at the highest doses employed the frequency of these cells remained low, with seldom more than 2 or 3 cells seen in each, medium-power field. The maximum number of celis was seen after 13 wk of treatment, and even after prolonged treatment there was no further increase in their number. After a long recovery period without treatment, there was only a gradual reduction in their numbers, and some MNHs were still present 12 mo after the end of dosing. All the studiesstarted with rats aged about 6 wk, an age at which they are still growing rapidly and when presumably the hepatocytes are still dividing at an appreciable rate. As the growth curve flattens off, it is likely that the rate ofdivision of hepatocytes slows down. The halflife for hepatocytes in adult rats is about 150 days (21) , and the mitotic index is low. This change in the rate of cell turnover may be the factor that influences the temporal pattern of the change associated with rifabutin. When account is taken of the long duration of recovery, it also appears that the life-span of the affected hepatocytes is not altered, since some survive for at least 1 yr.
From consideration of the other morphological changes in the liver where MNHs occur but neoplasia eventually develops, it is seen that the difference lies in the nature of the other changes that accompany the multinucleated cells. Varying forms of degeneration and necrosis are commonly seen and are followed by proliferative changes in the biliary tract or connective tissue. These are not seen in the early stages of treatment with rifabutin, although hypertrophy and pigment deposition are important features. It is concluded, therefore, that in terms of interpretation of the effects of treatment consideration should be given to the entire picture of liver pathology without giving undue emphasis to one particular morphological feature.
